Evidence map›Paper›PMID 31748840›Full record

ArticleActa neuropathologica2020

Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.

Eri Saijo, Michael A Metrick, Shunsuke Koga, Piero Parchi, Irene Litvan, Salvatore Spina, Adam Boxer, Julio C Rojas, Douglas Galasko, Allison Kraus and 8 more

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Diagnosis and Management of Progressive Corticobasal Syndrome.Current treatment options in neurology · 2024
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Eri SaijoLPVD, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, USA.
Michael A MetrickLPVD, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, USA.
Shunsuke KogaDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Piero ParchiIRCCS Istituto delle Scienze Neurologiche di Bologna, 40139, Bologna, Italy.
Irene LitvanDepartment of Neurosciences, Parkinson and Other Movement Disorders Center, University of California, San Diego, CA, USA.
Salvatore SpinaMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Adam BoxerMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Julio C RojasMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Douglas GalaskoDepartment of Neurosciences, University of California, San Diego, CA, USA.
Allison KrausLPVD, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, USA.
Marcello RossiIRCCS Istituto delle Scienze Neurologiche di Bologna, 40139, Bologna, Italy.
Kathy NewellIndiana University School of Medicine, Indianapolis, IN, USA.
Gianluigi ZanussoUniversity of Verona, Verona, Italy.
Lea T GrinbergMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
William W SeeleyMemory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Bernardino GhettiIndiana University School of Medicine, Indianapolis, IN, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Byron CaugheyLPVD, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, USA. bcaughey@nih.gov.ORCID http://orcid.org/0000-0002-3928-6101
University of California, San Francisco · USIndiana University School of MedicineIstituto delle Scienze Neurologiche di Bologna · ITMayo Clinic in Florida · USUniversity of California San Diego · USRocky Mountain Institute · USUniversidade de São Paulo · BRUniversity of Verona · IT

Funding

Technology and Remote Assessment CoreU19AG063911 · NIA · MAYO CLINIC ROCHESTER · PI Bradley F Boeve · 2019 to 2026
$120.9M
TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
The Four Repeat Tauopathy Neuroimaging InitiativeR01AG038791 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2010 to 2020
$18.1M
Multidisciplinary Research Fellowship in Alzheimer’s disease and Related DementiasT32AG023481 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRUCE L MILLER, HOWARD J ROSEN · 2005 to 2026
$7.4M
Training - The Frontotemporal Lobar Degeneration Clinical Research ConsortiumU54NS092089 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2014 to 2018
$6.4M
Neuropathological basis of brain network dysfunctionK08AG052648 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SPINA, SALVATORE · 2016 to 2020
$852k
NIA NIH HHS K08 AG052648NIA NIH HHS P01 AG019724NIA NIH HHS R01 AG038791NIA NIH HHS T32 AG023481NIA NIH HHS U19 AG063911NINDS NIH HHS U54 NS092089
6 · The paper itself

Abstract

The original version of this article unfortunately contained a mistake. The Panel A in the published figure 5 is incorrect. The corrected Figure 5 is placed in the following page.

Identifiers

PMID31748840
PMCPMC7193369
OpenAlexW2991037405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.